Cargando…
Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases
Retinal gene therapy is a rapidly growing field with numerous clinical trials underway, and route of delivery is a critical contributor to its success. Subretinal administration, which involves pars plana vitrectomy in the operating room, offers targeted delivery to retinal-pigment epithelium cells...
Autores principales: | Kansara, Viral, Muya, Leroy, Wan, Chen-rei, Ciulla, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404827/ https://www.ncbi.nlm.nih.gov/pubmed/32255727 http://dx.doi.org/10.1089/jop.2019.0126 |
Ejemplares similares
-
Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases
por: Wan, Chen-rei, et al.
Publicado: (2021) -
Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits
por: Kansara, Viral S., et al.
Publicado: (2021) -
Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits
por: Kansara, Viral S., et al.
Publicado: (2020) -
Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina
por: Muya, Leroy, et al.
Publicado: (2022) -
Suprachoroidal gene transfer with nonviral nanoparticles
por: Shen, Jikui, et al.
Publicado: (2020)